| |
|
|
|
Neu Base Therapeutics Inc  
|
|
8.09 0.14 (0.02%) |
11-24 16:00 |
|
Open: |
7.92 |
Pre close: |
7.95 |
Target:
|
10.01
|
|
High: |
8.22 |
Low: |
7.85 |
Resistance:
|
8.57
9.27
|
|
Volume: |
53,694 |
Market Cap: |
187M |
Support:
|
7.44
6.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.05
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
8.09  |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
8.18 |
Stochastic Oscillator |
%K(14,3):
|
53.41 |
|
MA(250): |
7.77 |
%D(3): |
54.88 |
|
Average Volume(K) |
3-Month: |
18666
|
52-Week |
High:
|
11.78 |
|
10-Days: |
11693 |
Low: |
4.52 |
|
RSI |
RSI(14):
|
48.45 |
Change(%): |
26.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-3.260 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-1.409 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
